Protease inhibitor use in 233 pregnancies.

Author Department

Medicine

Document Type

Article, Peer-reviewed

Publication Date

9-1-2005

Abstract

BACKGROUND: In the United States, as most highly active antiretroviral therapy (HAART) regimens used during pregnancy in HIV-infected women include a protease inhibitor (PI), it is important to determine the effects of PIs specifically rather than all HAA

Publication ISSN

0003-3022

Share

COinS